Deep tech
In the report: Hardware (micro, nano, semiconductors, space)
What Swiss startups raised, in which sectors, in which cantons and at which stage, based on public reports and supplemented by our own tracking of announcements. Every figure links to its source.
Published on 5 November 2026. Market data to 30 June 2026, our own tracking to 11 November 2026.
Venture capital invested in Swiss startups from January to June, in millions of francs. The first half of 2022 remains the bubble; since then the market has moved between 1.1 and 1.5 billion per half-year, with fewer and fewer rounds until 2025.
| First half | Capital invested | Rounds |
|---|---|---|
| 2022 | CHF 2,585.8 M | 163 |
| 2023 | CHF 1,195.5 M | 154 |
| 2024 | CHF 1,082.4 M | 138 |
| 2025 | CHF 1,473.7 M | 124 |
| 2026 | CHF 1,245.0 M | 123 |
The annual report covers 354 rounds, 303 of them with a known amount. Capital invested returned to its 2021 level, more than three times that of 2016, without the number of rounds increasing: rounds at the top of the market got bigger, not more numerous.3
All stages combined: CHF 2.6 million (CHF 3.0 million in 2024)
The report's categories do not match ours exactly. Each line gives the name used in the report and links to the sector page on FundSwiss, with its investors and recent rounds.
In the report: Hardware (micro, nano, semiconductors, space)
In the report: Biotech
In the report: Medtech and digital health
In the report: ICT (software, internet, AI)
In the report: Fintech
In the report: Cleantech
In 2025, Zurich remained the leading canton both in capital and in number of rounds, with capital up 89.5%, ahead of Vaud (+14.4%) and Basel-Stadt, which set a record thanks to biotech, with almost all its capital going to that sector. The top four cantons accounted for 88.6% of the amounts. Geneva recorded a record number of rounds, but no large round.34
The first half of 2026 reverses the ranking. Vaud passes CHF 330 million, driven by hardware: three of the four hardware rounds in the top 10 were raised there. Zurich posts a historically weak result, with no large biotech rounds and ICT funding stuck at a low level.1
For public funding in your canton, see Vaud, Zurich, Geneva or all 26 cantons.
The top three each exceed CHF 170 million.5 Amounts as announced, in their original currency.
| Company | Business | Amount | Stage |
|---|---|---|---|
| Kandou · Vaud | connectivity chips for AI, an EPFL spin-off | USD 225 M | Not specified |
| Terralayr · Zug | energy storage and grid flexibility | EUR 192 M | Not specified |
| CeQur | insulin delivery patch | USD 100 M | Series E |
| BLP Digital | automation with AI agents | USD 50 M | Not specified |
| Polares Medical | structural heart devices | USD 50 M | Series C |
| PAVE Space · Vaud | orbital transport | USD 40 M | Seed |
| NUCLIDIUM | radiopharmaceuticals | EUR 28.6 M | Series B extension |
| Acutronic | motion simulation, aerospace | USD 25 M | Not specified |
| Planetary | biomanufacturing by fermentation | EUR 23 M | Not specified |
List compiled by Tech.eu.6 Sources do not always agree: Deep Tech Nation puts Terralayr's round at CHF 178.3 million.5
Exits remain the weak link, even though they are the first condition for a venture capital recovery: funds only get money to reinvest by selling. In 2025, Switzerland counted 9 acquisitions valued at more than CHF 100 million, a record (among them Nexthink, Araris, Swixx BioPharma, Beekeeper), and two IPOs, BioVersys and MindMaze. In the first half of 2026, 21 exits were recorded, as many as a year earlier, with a clear rise in strategic investments, which often come before an acquisition.31
On the fund side, the survey of 112 managers in December 2025 shows a market on the move: 50 funds raising, 27 of them with a first closing, and 66% of managers planning to raise in 2026 (against 40% a year earlier), while 68% found fundraising conditions harder. 64% expected more exits and 60% higher valuations. In July, the half-year survey confirmed stronger optimism than a year earlier.31
To find out who invests at your stage and in your sector, the investor directory lists 110 funders active in Switzerland.
Since 3 November 2025, FundSwiss has tracked every round, grant and prize announced by Swiss startups. It is still a short sample: 430 fundings, too few for statistics, but it shows a reality that venture capital reports do not measure. 152 of these 430 fundings are non-dilutive (grants, loans, prizes).
If you are raising a seed round, the context is fairly favourable: seed amounts grew in the first half and the median seed round reached a record CHF 2.7 million.5 Investors remain selective, but the money is there for first rounds.
If you are preparing a Series A, expect it to take more time and more proof: early stage fell 29% in the first half after a record year. Plan for 18 to 24 months of runway and, where possible, combine with non-dilutive funding such as cantonal grants, Innosuisse or prizes and programmes with deadlines.
In deep tech and hardware, the wind is behind you: investors are looking for these projects, especially around EPFL and ETH. In biotech, large rounds are rare in 2026: early rounds can still be found, growth rounds take longer. In software and fintech, rounds remain mostly small.
The full-year review of 2026 will come out with the Swiss Venture Capital Report in January 2027. This page will be updated then.
The market figures come from the Swiss Venture Capital Report, published every year by startupticker.ch and SECA, which records the venture capital rounds publicly announced in Switzerland. Other studies use other scopes (tech companies in the broad sense, debt, grants) and reach different totals: we do not mix them. Amounts are as published, with no conversion on our part unless stated. Our own tracking is not comparable with the report: it includes grants, loans and prizes, and it is still recent.
Send us the link to the announcement: your round will join the rounds database and the benchmarks by stage.
Report a round